Theravance Biopharma TBPH Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on trailing twelve months.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's free cash flow yield?
- Theravance Biopharma (TBPH) reported free cash flow yield of 25.2% in Q4 2025.
- How has Theravance Biopharma's free cash flow yield changed year-over-year?
- Theravance Biopharma's free cash flow yield increased by 1080.9% year-over-year, from -2.6% to 25.2%.
- What is the long-term trend for Theravance Biopharma's free cash flow yield?
- Over 5 years (2020 to 2025), Theravance Biopharma's free cash flow yield has grown at a 2.3% compound annual growth rate (CAGR), from -22.4% to 25.2%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.